Skip to main content

Abstract

The authors examine U.S.-based evidence that connects characteristics of the social environment with outcomes across the psychosis continuum, from psychotic experiences to schizophrenia. The notion that inequitable social and economic systems of society significantly influence psychosis risk through proxies, such as racial minority and immigrant statuses, has been studied more extensively in European countries. While there are existing international reviews of social determinants of psychosis, none to the authors‘ knowledge focus on factors in the U.S. context specifically—an omission that leaves domestic treatment development and prevention efforts incomplete and underinformed. In this review, the authors first describe how a legacy of structural racism in the United States has shaped the social gradient, highlighting consequential racial inequities in environmental conditions. The authors offer a hypothesized model linking structural racism with psychosis risk through interwoven intermediary factors based on existing theoretical models and a review of the literature. Neighborhood factors, cumulative trauma and stress, and prenatal and perinatal complications were three key areas selected for review because they reflect social and environmental conditions that may affect psychosis risk through a common pathway shaped by structural racism. The authors describe evidence showing that Black and Latino people in the United States suffer disproportionately from risk factors within these three key areas, in large part as a result of racial discrimination and social disadvantage. This broad focus on individual and community factors is intended to provide a consolidated space to review this growing body of research and to guide continued inquiries into social determinants of psychosis in U.S. contexts.
Social determinants, which are social and environmental conditions experienced across the lifespan (1), produce health inequalities along a society’s social gradient in a way that disproportionately burdens the most marginalized and disadvantaged (2). In their theoretical model of social determinants, Compton and Shim (3) describe how policy and social norms create pervasive inequities in social and environmental conditions across the U.S. population—conditions that, both directly and in concert with biological risk, affect onset, severity, and remission of psychopathology (24). These social policies and norms influence access to important resources (e.g., education, health care, social capital) and exposure to environmental toxins and to stressors, such as childhood trauma, neighborhood deprivation, and discrimination (3). Within the U.S. context, one of the predominant organizing frameworks of these social policies and norms is structural racism (5, 6)—a socially constructed taxonomic stratification of power based on proximity to Whiteness, with individuals of African descent being the most distal category (7). Classic theoretical models, including Clark and colleagues’ biopsychosocial model of racism (8) and Harrell’s multidimensional model of racism-related stress (9), delineate the multiple pathways through which racism creates an accumulation of psychological and physiological stress responses that negatively affect health over time. Drawing on this framework, Link and Phelan applied their theoretical model of fundamental causes to describe how racism is a fundamental cause of health inequity in the United States (10, 11). In short, structural racism has an enduring association with health outcomes because it is maintained through multiple pathways by limiting access to flexible resources, such as those connected to neighborhood segregation and individual freedom to control life circumstances (10). Together, both theoretical models (3, 10) provide a framework for understanding how structural racism serves as a complex cause of mental health outcomes through social and environmental intermediary pathways connected to biological risk. Yet the study of such social determinants of psychosis has received limited investment in American psychiatry (12). More attention is often placed on understanding the biological and individual factors that lead to mental illness (3) despite increasing theoretical emphasis on the importance of the confluence of biological and social factors (1316).
European studies have consistently found higher psychosis incidence and prevalence among people with African and Caribbean heritage compared with majority White populations (17), highlighting the important etiological role of the social environment (e.g., social inequality, adversity, and discrimination [1821]) in psychosis risk (14). In one of the first empirical studies on psychosis incidence in a minoritized population, Ødegård (22) found in 1932 that Norwegian immigrants to the United States were twice as likely to be diagnosed with schizophrenia compared with U.S.-born individuals and those born and living in Norway. While racially similar to the contemporaneous dominant caste of American society (i.e., of European ancestry), the Norwegian immigrants were still othered and marginalized within the social hierarchy of that time for being immigrants. This study inspired a line of fruitful research examining associations between ethnic minority status and psychosis in primarily European countries. The United States, by contrast, has lagged behind Europe in examining the link between minority status and psychosis incidence. Our contemporary understanding of psychosis incidence in minoritized U.S. racial groups has been complicated by key factors, including the lack of a centralized health register to obtain an accurate denominator for incidence calculation; methodological issues with sample selection in epidemiological studies (e.g., differential access to health care based on race and socioeconomic status [23]); and misdiagnosis based on perceived racial group (24). While several U.S. studies have demonstrated that Black people and sometimes Latino people are overrepresented in the patient population with psychotic disorders (2529), these findings have been complicated by studies demonstrating that clinicians tend to misinterpret and misattribute symptomatic phenomenology presented by Black people, resulting in the overdiagnosis of schizophrenia and underdiagnosis of affective disorders (3035). The strongest evidence of a racial disparity in psychosis comes from a Kaiser Permanente California birth cohort study (36) that demonstrated a threefold elevated risk of schizophrenia spectrum diagnoses for Black members compared with White members; however, after adjustment for several socioeconomic status indicators, this risk was reduced to 1.92, with a confidence interval that narrowly included zero. Additionally, evidence from nationally representative epidemiological studies (3739) shows higher 12-month prevalence estimates of psychotic symptoms among Black (e.g., 15.3%) and Latino (e.g., 13.6%) Americans compared with White Americans (e.g., 9.7%) (40). To date, the United States has not adopted a representative, population-based approach sufficiently powered for the study of clinical psychosis incidence that simultaneously adjusts for race-based misdiagnosis and related socioeconomic disadvantage. Such investment is critical to have stable, reliable estimates of any racial disparity in psychosis risk. The lack of clarity on this issue has stymied efforts to elucidate the relationship between racial and ethnic minoritization and psychosis in the United States.
Even though psychosis incidence and prevalence across racial groups in the United States remains inconclusive, the central role that structural racism plays in shaping the distribution of risk factors for psychosis across the U.S. population is less equivocal. This social taxonomy in the United States has roots in a racial trauma history that gave rise to a pervasive system of structural racism that persists today (41). The genocide of First Nations people, the theft of their land, and the enslavement of over 3.9 million Africans and their American-born descendants (42) to build White American wealth and capital are historical traumas embedded in the foundation of the United States and its legacy of oppression, segregation, and economic injustices (e.g., Jim Crow laws, mass incarceration) (43). The repercussion of this legacy is evident in sharp inequities along racial lines (44). A striking example of this inequity exists in New Jersey, where the racial differences in wealth are extreme, with the median net worth for White families at $309,396 compared with just $7,020 and $5,900, respectively, for Latino and Black families (45). This inequity necessarily translates into very different lived experiences on average in education, health care, and neighborhood exposures—inequities widened further because important services in the United States (e.g., schools) are funded through property taxes.
This narrative review seeks to provide the first consolidated integration of U.S.-based work on social determinants of psychosis in three key areas, with a specific focus on race and ethnicity. Being of a particular race in and of itself is not the determinant; the systematic racism that constructs the social milieu makes it relevant. Figure 1 presents a hypothesized model of how a lineage of structural racism shapes psychosis risk through social determinants at multiple levels, including those of the neighborhood and the individual. Specifically, this review focuses on risk factors within U.S. neighborhoods, trauma experienced at both collective and individual levels, and complications experienced during perinatal periods. These areas were chosen in part because of their consistent link to psychosis and how they are shaped by structural racism, although we acknowledge that they are not exclusively linked to psychosis. Studies reviewed highlight the U.S. context’s uniqueness and provide suggestions for further inquiry. Our aim is not to exhaustively review the evidence on all social determinants of psychosis, but to highlight those that seem particularly relevant for the U.S. context. We offer the model in Figure 1 as an overall framework worthy of future empirical inquiry, outlining the interconnected social mechanisms of disadvantage identified in previous European studies (46) and underlying increased stress and other biological consequences linked with psychosis outcomes in the United States. We include studies across the psychosis continuum, from psychotic experiences in non-treatment-seeking community samples (e.g., the Collaborative Psychiatric Epidemiology Surveys) (47) to psychosis risk syndrome in clinical high-risk population studies (e.g., the North American Prodrome Longitudinal Study) (48) to psychotic disorders such as schizophrenia in clinical settings (30). We also include selected studies that connect these social determinants to possible underlying biological mechanisms, implicating stress hormones (16, 49, 50), neural activity and connectivity (51, 52), and epigenetic mechanisms (53).
FIGURE 1. Hypothesized model of systemic racism and psychosis in the United States

THE NEIGHBORHOOD

Neighborhood-level factors cover a broad range of social, economic, and political conditions, including urbanicity, ethnic density, perceived neighborhood disorder (e.g., vandalism and other signals of loss of social control), residential stability, and access to resources, opportunities, and services. Among other mental health concerns, given the link between stress and psychosis (54), adverse neighborhood conditions are associated with an increased prevalence and severity of the extended psychosis phenotype (55).
U.S. neighborhoods have evolved to systematically and generationally perpetuate disadvantage (41) for racially minoritized communities (56) through both formal and informal generational segregation and discrimination (57, 58). These forces maintain systemic inequity in community-wide access to resources, services, wealth, and opportunities (59) comprising access to healthy foods, safe water, clean air, parks, affordable childcare, health care, education, employment opportunities, and safe housing (60). All of these neighborhood factors confer disadvantage that is associated with cumulative stress (61) (see Figure 1) and therefore conceivably linked to heightened risk for psychosis (54).
In an early study, Faris and Dunham (62) showed that urbanicity—residing in a more population-dense area—was related to higher schizophrenia rates, a finding that applied to both Black and White people. Hollingshead and Redlich (63) continued this work by examining the relation between social class and mental health disorders, finding disproportionate rates of psychotic disorders among individuals of the lowest socioeconomic status, including many people of color.
Narita et al. (64) found that higher neighborhood disruption (e.g., fear of being “pushed out” of one’s neighborhood or a perceived decline in local social networks) was associated with significantly greater odds of endorsing a psychotic experience in a large U.S. community sample. In a related study, Anglin et al. (65) examined perceived neighborhood ethnic density in a large sample of young adults in an urban setting. Respondents who grew up in neighborhoods predominantly populated by a different ethnic or racial minoritized group endorsed a higher number of psychotic experiences than those who grew up in White, mixed, or racially concordant neighborhoods. These findings suggest that growing up with the experience of stressful racial dynamics in an urban community may lead to increased risk for psychosis spectrum experiences. Additionally, Ku et al. (66) reported that neighborhood-level residential instability, as measured by the percentage of people who lived in multiple homes within 1 year, predicted earlier psychosis onset, a proxy for more severe illness course.
Future research in the United States could probe for a more refined understanding of the mechanisms that underlie the links between neighborhood-level factors and psychosis risk. For instance, lack of green space (67) and exposure to environmental toxins (68) correlate with psychosis in European studies. Additionally, the use of objective measures of neighborhood disorder and disruption could complement existing assessment strategies that focus on subjective accounts, providing an opportunity to better understand the relation between objective and subjective evaluation of neighborhoods, and better steer intervention strategies. Objective measures may include the use of geocoding and the mapping of addresses, which can be compared with publicly available information about a neighborhood, such as average socioeconomic status, crime, and local resources.

TRAUMA IN A U.S. CONTEXT

Acute or chronic traumatic events and major life stressors have an impact on psychosocial and biological stress responses, which may contribute to the pathogenesis of psychosis (54, 6971). In the United States, studies have focused primarily on the impact of adverse childhood experiences (e.g., abuse, neglect, incarcerated family members), showing that at least 61% of individuals in the U.S. population endorse at least one event, with racial and ethnic minoritized individuals having higher adverse childhood experience exposure rates (69). Findings in the general population appear to differ by trauma type, with White Americans reporting an overall higher traumatic event incidence (72), but minoritized racial groups reporting a higher incidence of childhood maltreatment and exposure to violence (72). U.S.-based research has identified various traumatic events as potential contributors to psychosis risk, including adverse childhood experiences, such as emotional or physical neglect (7375), psychological or physical bullying (7678), developmental challenges associated with foster care (79), and parental separation or death (80, 81). Perceived discrimination has also been associated with psychosis (76, 82, 83).
Trauma and adverse childhood experiences are common among individuals with schizophrenia, with 86% of individuals with schizophrenia surveyed in one study reporting at least one adverse childhood experience (81). Those at clinical high risk for psychosis also report having had at least one traumatic experience (∼85%−97%) (80, 84), with many individuals endorsing more than one traumatic experience (81, 84). In the U.S. National Comorbidity Survey, experiencing one trauma type was not associated with psychosis outcomes, but experiencing more than one was, indicating a possible compounding effect (85). More frequent victimization, trauma, or stressors is associated with increased psychotic symptom frequency or severity in a dose-response pattern (73, 8587). This is relevant as revictimization is high after an initial trauma (88).
Across the psychosis continuum, trauma and adversity rates, including for physical abuse (80), sexual abuse (81), domestic violence (81), separation from a parent (i.e., divorce, raised by nonbiological caregivers) (89), and parental death (81), are significantly higher for marginalized racial groups compared with White people. Socioenvironmental adversity, often found in more disadvantaged racially minoritized communities, may intersect with collective historical racial trauma to increase exposure to chronic stress and traumatic events.
Police victimization and gun violence are examples of significant social health crises disproportionately affecting racially minoritized communities in the United States (90, 91), as Black, First Nation, and Latino men are killed by police at higher rates compared with White men (90). Police violence in particular may be more impactful on mental health because it is enacted by people who are state sanctioned to enact violence and there is little legal recourse for such violence (92). Black men, specifically, have a 1 in 1,000 chance of being a victim of lethal force by police over their lifetime, in contrast to 39 in 100,000 for their White counterparts (93). In addition, Black and Latino individuals have a disproportionately higher rate of exposure to gun violence fatalities (94). Death by police violence and homicide by firearm are leading causes of death of young Black men (93, 95, 96).
This creates a unique type of collective trauma in the United States, where communities have been intimately or vicariously affected by the trauma of police victimization and gun violence. In a diverse sample from four large U.S. urban centers, individuals who self-reported different types of police victimization (e.g., physical [with or without a weapon], sexual, psychological, neglect) were more likely to report psychotic experiences (97). Likewise, greater exposure to gun violence fatalities, regardless of police involvement, was positively associated with psychotic experiences (94). Given that other similarly educated countries, such as England and Japan, report zero to seven police killings per year, compared with the average of 1,100 incidents per year in the United States (97), police victimization and gun violence should receive more attention as stress- and trauma-related social determinants of psychosis risk in the United States.

RACIAL DISPARITIES DURING PRE- AND PERINATAL PERIODS

A variety of obstetric complications have been associated with increased risk for psychotic disorders in U.S. samples (98). Various infections (99), increases in maternal inflammation (100, 101), maternal stress (102, 103), hypoxia-associated obstetric complications (i.e., decreased oxygen to the fetus [104]), decreased fetal growth [105, 106]), lower maternal hemoglobin levels (107), and alterations in various nutrients (108) during pregnancy have been linked to increased prevalence of psychotic disorders in the United States (109). All of these prospective results have been based on birth cohorts that enrolled pregnant women during the 1950s and 1960s and followed them and their offspring, collecting thousands of variables, including prenatal blood samples (110, 111). Nevertheless, not only do these studies suffer from cohort effects due to political climates and demographic characteristics that are not generalizable to contemporary samples, but also none of these studies adequately incorporated known racial and ethnic disparities in birth complications commonly found in the United States into their explanatory models.
The latter point is of paramount importance, given that Black women in the United States are at substantially increased risk for many obstetric complications, spanning preterm delivery, reduced fetal growth, and increased infection rates (112, 113). Importantly, findings indicate that access to prenatal care and a variety of sociodemographic factors (e.g., income) do not explain racial disparities in birth outcomes (114). Moreover, Black women with higher socioeconomic status have an increased risk of obstetric complications compared with non-Hispanic White women with lower socioeconomic status (114). Neighborhood- and individual-level factors appear to affect the disparity in these outcomes. A recent study revealed that exposure to environmental contaminants (e.g., air pollution, heat exposure) is linked to higher rates of preterm birth and low birth weight differentially in Black mothers compared with other mothers in the United States (115), possibly as a result of an interaction between prenatal stress and contaminants (116). Additionally, psychological distress related to perceived neighborhood crime levels and breakdown of order and social control have also been linked to preterm birth in Black mothers (117). Studies also have found that Black women experience a higher number of stressors during pregnancy, although these stressful life events on their own do not appear to account for racial disparities in obstetric complications when considering events that do not include discrimination (118). Other findings suggest that perceived discrimination significantly predicted lower birth weight among Black women, but not in other racial or ethnic groups (119). In fact, both objective measures of neighborhood environment and perceived racial discrimination have been associated with increased psychological distress in pregnant Black women (117).
Findings also indicate that Black women are more likely to have lower cortisol levels during the second trimester of pregnancy compared with other racial and ethnic groups (120). Lower second-trimester cortisol levels are consistent with what has been observed among women diagnosed with posttraumatic stress disorder and has been interpreted as potentially related to a lifetime of exposure to increased stress due to repeated discriminatory experiences (120). Not only is cortisol essential for fetal growth and development, but findings indicate that lower cortisol levels in later stages of pregnancy are associated with decreased fetal growth among those who develop schizophrenia (105, 121123). Black women may also be more sensitive to the effects of stress hormones during pregnancy, with some findings suggesting that smaller increases in stress hormones produce poor birth outcomes, such as preterm delivery, among these pregnancies (124). In addition, Black women show higher levels of other stress biomarkers as compared with White women of the same socioeconomic status in mid to late pregnancy, including particular inflammatory markers (e.g., C-reactive protein) and adrenocorticotropic hormone (125, 126). Furthermore, Black women have shown a more robust inflammatory response to a laboratory stressor than White women in mid-pregnancy, and elevated inflammatory cytokines were related to experiences of perceived discrimination (98). In their review of racism and perinatal effects, Conradt et al. (127) argue that discriminatory experiences in pregnant women of color may increase allostatic load, wearing down the body’s regulatory systems, causing biological and epigenetic changes in the infant as well as differences in birth outcomes. Cumulatively, these findings highlight a complex picture, with both decreased and increased maternal cortisol levels and other stress biomarkers, potentially leading to poor birth outcomes and subsequent risk for psychotic disorders in adulthood.
Finally, there is evidence that many Latina women have lower birth complication rates if they are recent immigrants to the United States (128); however, the longer Latina women stay in the United States, the more similar the obstetric complication rates become to those for Black women (129, 130). These findings may be due in part to cumulative (and potentially intergenerational) exposure to discrimination during the acculturation process (131133). Studies have also identified a relationship between greater acculturation and blunted maternal cortisol response (134) in addition to elevated concentrations of the inflammatory cytokine interleukin-6 (135), which may be biological mechanisms through which acculturation has an impact on adverse birth outcomes. Overall, these findings suggest that racial and ethnic disparities in the rates of obstetric complications in the United States could contribute to a developmental trajectory toward psychosis and findings of higher schizophrenia rates among Black individuals, immigrant populations, and potentially other less studied groups that experience high discrimination rates (e.g., because of religion, sexuality, and other racial and ethnic identities).

DISCRIMINATION AND POSSIBLE BIOLOGICAL MECHANISMS LINKED TO PSYCHOSIS

Figure 1 illustrates structural racism as a fundamental cause of the extended psychosis phenotype through group-level processes occurring at the neighborhood level that are connected to processes occurring at the individual level (e.g., discrimination). Neighborhood-level factors (e.g., exposure to environmental contaminants, concentrations of crime) likely interact with the psychological ones to enhance chronic stress across generations, especially given how neighborhoods in the United States are structured to preserve advantages or disadvantages over time. Experiences of discrimination underlie the chronic stress experienced by many racial and ethnic minoritized individuals—stress that has been linked to physiological and neurobiological mechanisms, including psychophysiological stress responses shaped by threat appraisals and immune responses (136). Such racial discrimination has been associated with paranoia in a dose-response pattern in nonclinical populations (psychotic experiences in Hispanic/Latino, Asian American, and Black American individuals) (82, 137, 138) and clinical populations (48, 76).
Our review of obstetric complications suggests that discrimination among Black and Latina mothers may contribute to these complications because of heightened responses to stress (e.g., inflammatory responses)—responses in offspring that are also caused by obstetric complications (103). Other longitudinal work on possible biological mechanisms linking discrimination with psychosis risk indicates that such experiences can contribute to chronic activation of stress systems, leading to long-term changes in neural circuitry responsible for regulating emotional learning and the pairing of threat cues to neutral stimuli (139). One study (139) found that for racial and ethnic minoritized people, prior negative life experiences, such as discrimination, explained racial differences in threat-related neural and psychophysiological activity. Other work (52) highlighted how discriminatory experiences may affect underlying neural systems in similar ways to other stressful experiences. Clark et al. (52) found that higher levels of social discrimination in racial and ethnic minoritized populations were correlated with increased spontaneous amygdala activity and increased functional connectivity with other brain regions, particularly the thalamus. This neural activation pattern is similar to processing of other stressful experiences. Given the history of oppression, discrimination, and systemic racism in the United States, understanding the biological consequences of the unique trauma and stressors of minoritized communities will expand our understanding of risk for psychosis more generally.
Recently, Gur et al. (140) conducted a longitudinal study exploring how environmental determinants, such as traumatic-stressful events and low socioeconomic status, affect neurodevelopment and brain function. They found that traumatic, stressful events and low socioeconomic status throughout adolescent development caused brain development to be completed earlier in addition to an overall reduction in volume. Other recent developmental work highlights the possible epigenetic effects of discrimination in African Americans. Carter et al. (141), using gene expression data from the Family and Community Health Study, found that high exposure to discrimination during early adolescence was associated with depression in adulthood and accelerated cellular-level aging. The role of epigenetic mechanisms provides a promising avenue for future study and should be explored further in relation to psychosis etiology.

RECOMMENDATIONS

To truly adopt an antiracist framework, it is necessary to walk in the opposite direction on the path that seeks to maintain the status quo (142). The evidence reviewed suggests that a greater appreciation of how racism shapes social determinants of psychosis would support such a framework in North American psychiatry. As a fundamental cause of mental health inequities, structural racism and the social policies and norms it shapes (e.g., preservation of neighborhood disadvantage) must be dismantled to have a complete solution. Simultaneously adjusting health care policy and how we approach early intervention for psychosis among Black and other racially minoritized groups is also necessary. As an example, health care policies could be reimagined to provide psychological intervention and protection to circumvent the detrimental impact of racial discrimination and stress on Black mothers. Many generalized stress interventions have been tested (143, 144), but to our knowledge, there are no evidence-based interventions specifically designed to tackle race-based discrimination stress in racially minoritized pregnant mothers.
Altogether, the current evidence suggests the need to identify, address, and tackle the social determinants deeply ingrained in U.S. society, in tandem with empowering the most marginalized communities. This has the potential to lead to mental health benefits not yet attained, as there is evidence of a large unmet health care need among young people with psychosis, especially within racially minoritized communities in the United States (145). We recommend that the field of psychiatry devote considerably more effort to addressing structural racism and social determinants of psychosis in funding priorities, training, and intervention development.

Funding Priorities and Training

In light of the morbidity and stigma associated with psychosis and schizophrenia specifically, a strong federally funded research program designed to provide reliable psychosis incidence estimates across racial and ethnic groups in the United States that systematically account for misdiagnosis is urgently needed. Relatedly, funding intervention development efforts that include multilevel targets, including those at the neighborhood level, such as those connected to collective racial trauma, may better capture an important area of risk that our review suggests contributes to psychosis outcomes. Definitive causal evidence is lacking because the critical studies have not yet been carried out, but the available evidence points to a social system of contributory causes for psychosis in the United States that may require multilevel interventions. Such interventions require equitable community partnerships that target the health of the community and include the perspective of institutions and organizations within communities (146). As an example, Hankerson et al. (147) are using community-partnered participatory research principles to develop and implement a depression intervention that incorporates the neighborhood-level perspective of African American churches in the local community. More funding for these approaches is needed, as they provide an opportunity to include community-level targets in interventions that would not otherwise be revealed. (See Castillo et al. [146], for other detailed examples of community-level interventions.)
In terms of training, a better integration of the work on racial trauma (148) in mental health training and practice would improve the ability to adequately assess for context indicators and to intervene in racially minoritized populations. The DSM-5 Cultural Formulation Interview (149), which includes a specific section on factors within the social environment, could be used as a tool to better integrate such experiences in patient assessments. This interview broadly assesses the role of culture and context on illness presentation and the diagnostic process (150). Incorporating a cultural formulation in the diagnosis of psychosis has been shown to facilitate reasoning and decision making about symptoms and behaviors presented by Black immigrants in Canada, leading to enhanced diagnostic clarity (151). More training regarding how to use cultural formulations to integrate information about collective racial trauma in the social environment would support efforts to optimize and personalize treatments for racially minoritized persons with psychosis. Relatedly, a training system that requires mental health care professionals and leaders to increase their focus on structural competencies (152) is needed. This proficiency in structural competency includes understanding how inequities in social and economic conditions shape clinical presentations, practitioner-patient interactions, and the course and efficacy of treatment once symptoms emerge across all stages of illness.

Intervention Development

Optimizing and personalizing interventions for people with psychosis are major federal funding and public health priorities (153). Yet, there is generally a lack of empirically supported treatments to support those who have experienced racial discrimination despite its apparent role in mental illness etiology, including for psychosis. For Black and other culturally minoritized groups, treatment optimization and personalization could be enhanced if these social determinants connected to racism were adequately incorporated into early intervention and treatment models. As an example, Weisman de Mamani et al. (154) developed a culturally informed manualized treatment for schizophrenia that focuses on family collectivism and enhancing adaptive spiritual beliefs and practices. This treatment helped reduce psychiatric symptom severity and improve quality of life, especially for Hispanic patients with schizophrenia.
There are no early intervention or treatment programs for psychosis, to our knowledge, that directly target the pernicious aspects of racism that affect Black and other culturally minoritized groups. Treatment paradigms for psychosis that focus solely on individual psychotherapy without incorporating the role of social context may be missing a significant part of the etiological variance. Multilevel (community and individual) and intergenerational approaches to the early intervention and treatment of psychosis should be considered and tested in studies using mixed methods. Neblett (155) described the value of using qualitative approaches, such as Photovoice (156), to study how racism affects Black youth in the local community. Photovoice is a community-based participatory research approach in which participants have the opportunity to photograph issues and themes that are of importance to the community, and through these photos, a better understanding of these issues emerges as well as a dialogue with previously marginalized or neglected voices (157). Participatory methods similar to Photovoice can reveal novel ways to develop treatments that incorporate tackling racism in the community because it prioritizes the voice and perspective of a segment of the population that is underrepresented among researchers and clinicians (158, 159). There is enhanced probability to reveal something innovative and constructive.

CONCLUSIONS

Our review of the U.S.-based literature on social determinants reveals a pattern of racial disparities in established risk factors for psychosis. That racism has historically structured U.S. societal systems means that the neighborhood and social context may hold a significant portion of the relative contribution of risk for psychosis. This may occur through individual-level discrimination as well as through collective trauma at the community level (e.g., police and gun violence). The evidence that these multilevel exposures may enhance chronic stress activation across generations through perinatal complications in mothers is considerable. Furthermore, evidence regarding the neurodevelopmental and neurobiological effects of discrimination, especially regarding long-term changes in neural circuits responsible for pairing threat cues to neutral stimuli, make it a critical target for further research and intervention development. Social and environmental stressors connected to structural racism (e.g., neighborhood disadvantage, collective trauma, discrimination) that are disproportionately experienced by Black and Indigenous people of color could contribute to psychosis risk in these populations. While our review revealed that much of the work in this area has focused on Black and Latino populations, these social determinants are likely also relevant for Indigenous and Asian-descended populations; more research is needed in these populations.
The disproportionate number of marginalized and disadvantaged Black people represented among individuals with psychosis in U.S. clinical settings may reflect how these traumas, discrimination, and neighborhood violence are influencing the ability to receive adequate treatment and avoid traumatic pathways to and through care. Indeed, perceived neighborhood disorder in childhood and adolescence significantly predicted delays in identification and receipt of mental health services for people with a diagnosis of psychosis (66). Other marginalized groups, encompassing those in poor rural areas, the lesbian, gay, bisexual, transgender, queer, and intersex community (especially transgender people of color), and those with disabilities also suffer disproportional social determinants of health. Building a critical consciousness about the ways behaviors and symptoms are connected to the contexts in which we live, including in our training programs, among providers, and in our patients, can enhance practice effectiveness. More research studies that use both qualitative and quantitative methods will be necessary to fully understand the interplay between adversity, minority status, and other dynamic factors within U.S. communities and how the unique experiences of these marginalized groups influence psychotic experiences, illness development, access to care, and ability to recover.

REFERENCES

1.
Centers for Disease Control and Prevention : Social Determinants of Health, 2018. https://health.gov/healthypeople/objectives-and-data/social-determinants-health
2.
Allen J, Balfour R, Bell R, et al : Social determinants of mental health. Int Rev Psychiatry 2014 ; 26 : 392 – 407
3.
Compton MT, Shim RS : The social determinants of mental health. Focus 2015 ; 13 : 419 – 425
4.
Silva M, Loureiro A, Cardoso G : Social determinants of mental health: a review of the evidence. Eur J Psychiatry 2016 ; 30 : 259 – 292
5.
Williams DR, Mohammed SA : Racism and health, I: pathways and scientific evidence. Am Behav Sci 2013 ; 57 : 1152 – 1173
6.
Cogburn CD : Culture, race, and health: implications for racial inequities and population health. Milbank Q 2019 ; 97 : 736 – 761
7.
Guess TJ : The social construction of whiteness: racism by intent, racism by consequence. Crit Sociol 2006 ; 32 : 649 – 673
8.
Clark R, Anderson NB, Clark VR, et al : Racism as a stressor for African Americans: a biopsychosocial model. Am Psychol 1999 ; 54 : 805 – 816
9.
Harrell SP : A multidimensional conceptualization of racism-related stress: implications for the well-being of people of color. Am J Orthopsychiatry 2000 ; 70 : 42 – 57
10.
Phelan JC, Link BG : Is racism a fundamental cause of inequalities in health? Annu Rev Sociol 2015 ; 41 : 311 – 330
11.
Link BG, Phelan J : Social conditions as fundamental causes of disease. J Health Soc Behav 1995 ; ( spec no ): 80 – 94
12.
Anglin DM, Galea S, Bachman P : Going upstream to advance psychosis prevention and improve public health. JAMA Psychiatry 2020 ; 77 : 665 – 666
13.
Insel TR : Rethinking schizophrenia. Nature 2010 ; 468 : 187 – 193
14.
van Os J, Kenis G, Rutten BPF : The environment and schizophrenia. Nature 2010 ; 468 : 203 – 212
15.
Howes OD, McCutcheon R : Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization. Transl Psychiatry 2017 ; 7 : e1024
16.
Pruessner M, Cullen AE, Aas M, et al : The neural diathesis-stress model of schizophrenia revisited: an update on recent findings considering illness stage and neurobiological and methodological complexities. Neurosci Biobehav Rev 2017 ; 73 : 191 – 218
17.
Selten JP, van der Ven E, Termorshuizen F : Migration and psychosis: a meta-analysis of incidence studies. Psychol Med 2020 ; 50 : 303 – 313
18.
Morgan C, Knowles G, Hutchinson G : Migration, ethnicity, and psychoses: evidence, models, and future directions. World Psychiatry 2019 ; 18 : 247 – 258
19.
Kirkbride JB, Jones PB, Ullrich S, et al : Social deprivation, inequality, and the neighborhood-level incidence of psychotic syndromes in East London. Schizophr Bull 2014 ; 40 : 169 – 180
20.
Janssen I, Hanssen M, Bak M, et al : Discrimination and delusional ideation. Br J Psychiatry 2003 ; 182 : 71 – 76
21.
Veling W, Selten J-P, Susser E, et al : Discrimination and the incidence of psychotic disorders among ethnic minorities in the Netherlands. Int J Epidemiol 2007 ; 36 : 761 – 768
22.
Ødegård Ø : Emigration and Insanity: A Study of Mental Disease Among the Norwegian Born Population of Minnesota. Copenhagen, Levin & Munksgaard, 1932
23.
van der Ven E, Kirkbride JB : Understanding racial-ethnic disparities in psychosis outcomes via population-based approaches. Psychiatr Serv 2018 ; 69 : 1121
24.
Schwartz EK, Docherty NM, Najolia GM, et al : Exploring the racial diagnostic bias of schizophrenia using behavioral and clinical-based measures. J Abnorm Psychol 2019 ; 128 : 263 – 271
25.
Lawson WB, Hepler N, Holladay J, et al : Race as a factor in inpatient and outpatient admissions and diagnosis. Hosp Community Psychiatry 1994 ; 45 : 72 – 74
26.
Barnes A : Race, schizophrenia, and admission to state psychiatric hospitals. Adm Policy Ment Health Ment Health Serv Res 2004 ; 31 : 241 – 252
27.
Snowden LR, Cheung FK : Use of inpatient mental health services by members of ethnic minority groups. Am Psychol 1990 ; 45 : 347 – 355
28.
Blow FC, Zeber JE, McCarthy JF, et al : Ethnicity and diagnostic patterns in veterans with psychoses. Soc Psychiatry Psychiatr Epidemiol 2004 ; 39 : 841 – 851
29.
Strakowski SM, Shelton RC, Kolbrener ML : The effects of race and comorbidity on clinical diagnosis in patients with psychosis. J Clin Psychiatry 1993 ; 54 : 96 – 102
30.
Strakowski SM, Hawkins JM, Keck JE Jr, et al : The effects of race and information variance on disagreement between psychiatric emergency service and research diagnoses in first-episode psychosis. J Clin Psychiatry 1997 ; 58 : 457 – 463
31.
Adebimpe VR : Overview: White norms and psychiatric diagnosis of Black patients. Am J Psychiatry 1981 ; 138 : 279 – 285
32.
Mukherjee S, Shukla S, Woodle J, et al : Misdiagnosis of schizophrenia in bipolar patients: a multiethnic comparison. Am J Psychiatry 1983 ; 140 : 1571 – 1574
33.
Simon RJ, Fleiss JL, Gurland BJ, et al : Depression and schizophrenia in hospitalized Black and White mental patients. Arch Gen Psychiatry 1973 ; 28 : 509 – 512
34.
Strakowski SM, Flaum M, Amador X, et al : Racial differences in the diagnosis of psychosis. Schizophr Res 1996 ; 21 : 117 – 124
35.
Gara MA, Minsky S, Silverstein SM, et al : A naturalistic study of racial disparities in diagnoses at an outpatient behavioral health clinic. Psychiatr Serv 2019 ; 70 : 130 – 134
36.
Bresnahan M, Begg MD, Brown A, et al : Race and risk of schizophrenia in a US birth cohort: another example of health disparity? Int J Epidemiol 2007 ; 36 : 751 – 758
37.
Olfson M, Lewis-Fernández R, Weissman MM, et al : Psychotic symptoms in an urban general medicine practice. Am J Psychiatry 2002 ; 159 : 1412 – 1419
38.
Paksarian D, Merikangas KR, Calkins ME, et al : Racial-ethnic disparities in empirically-derived subtypes of subclinical psychosis among a US sample of youths. Schizophr Res 2016 ; 170 : 205 – 210
39.
Leaune E, Dealberto MJ, Luck D, et al : Ethnic minority position and migrant status as risk factors for psychotic symptoms in the general population: a meta-analysis. Psychol Med 2019 ; 49 : 545 – 558
40.
Cohen CIL, Marino L : Racial and ethnic differences in the prevalence of psychotic symptoms in the general population. Psychiatr Serv 2013 ; 64 : 1103 – 1109
41.
Gee GC, Ford CL : Structural racism and health inequities: old issues, new directions. Du Bois Rev 2011 ; 8 : 115 – 132
42.
Kennedy JCG : Agriculture of the United States in 1860, Compiled From the Original Returns of the Eighth Census. Washington, DC, Government Printing Office, 1864
43.
Sotero M : A conceptual model of historical trauma: implications for public health practice and research. J Health Dispar Res Pract 2006 ; 1 : 93 – 108
44.
Feagin J, Bennefield Z : Systemic racism and US health care. Soc Sci Med 2014 ; 103 : 7 – 14
45.
New Jersey Institute for Social Justice: Reclaiming the American Dream: Expanding Financial Security and Reducing the Racial Wealth Gap Through Matched Savings Accounts. Newark, New Jersey Institute for Social Justice, 2019
46.
Jongsma HE, Gayer-Anderson C, Tarricone I, et al : Social disadvantage, linguistic distance, ethnic minority status, and first-episode psychosis: results from the EU-GEI case-control study. Psychol Med (Online ahead of print, March 3, 2020)
47.
Alegria M, Jackson JS, Kessler RC, et al : Collaborative Psychiatric Epidemiology Surveys (CPES), 2001–2003 (United States). Ann Arbor, Mich, Inter-University Consortium for Political and Social Research ( https://doi.org/10.3886/ICPSR20240.v8 )
48.
Addington J, Cadenhead KS, Cannon TD, et al : North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull 2007 ; 33 : 665 – 672
49.
Fuller-Rowell TE, Doan SN, Eccles JS : Differential effects of perceived discrimination on the diurnal cortisol rhythm of African Americans and Whites. Psychoneuroendocrinology 2012 ; 37 : 107 – 118
50.
Mittal VA, Walker EF : Advances in the neurobiology of stress and psychosis. Schizophr Res 2019 ; 213 : 1 – 5
51.
Meyer-Lindenberg A, Tost H : Neural mechanisms of social risk for psychiatric disorders. Nat Neurosci 2012 ; 15 : 663 – 668
52.
Clark US, Miller ER, Hegde RR : Experiences of discrimination are associated with greater resting amygdala activity and functional connectivity. Biol Psychiatry Cogn Neurosci Neuroimaging 2018 ; 3 : 367 – 378
53.
Smigielski L, Jagannath V, Rössler W, et al : Epigenetic mechanisms in schizophrenia and other psychotic disorders: a systematic review of empirical human findings. Mol Psychiatry 2020 ; 25 : 1718 – 1748
54.
Corcoran C, Walker E, Huot R, et al : The stress cascade and schizophrenia: etiology and onset. Schizophr Bull 2003 ; 29 : 671 – 692
55.
Allardyce J, Boydell J : Review: the wider social environment and schizophrenia. Schizophr Bull 2006 ; 32 : 592 – 598
56.
Lichter DT, Parisi D, Taquino MC : The geography of exclusion: race, segregation, and concentrated poverty. Soc Probl 2012 ; 59 : 364 – 388
57.
Campbell KE, Marsden PV, Hurlbert JS : Social resources and socioeconomic status. Soc Networks 1986 ; 8 : 97 – 117
58.
Massey DS : American apartheid: segregation and the making of the underclass. Source Am J Sociol. 1990 ; 96 : 329 – 357
59.
Massey DS : Residential segregation and neighborhood conditions in US metropolitan areas, in America Becoming: Racial Trends and Their Consequences. Edited by Smelse NJ, Wilson JW, Mitchell F. Washington, DC, National Academies Press, 2001, pp 391 – 434
60.
Assari S : Unequal gain of equal resources across racial groups. Int J Health Policy Manag 2018 ; 7 : 1 – 9
61.
Walker SP, Wachs TD, Grantham-Mcgregor S, et al : Inequality in early childhood: risk and protective factors for early child development. Lancet 2011 ; 378 : 1325 – 1338
62.
Faris R, Dunham H : Mental Disorders in Urban Areas: An Ecological Study of Schizophrenia and Other Psychoses. Chicago, University of Chicago Press, 1939
63.
Hollingshead AB, Redlich FC : Social Class and Mental Illness: Community Study, Social Class, and Mental Illness: Community Study. New York, John Wiley & Sons, 1958
64.
Narita Z, Knowles K, Fedina L, et al : Neighborhood change and psychotic experiences in a general population sample. Schizophr Res 2020 ; 216 : 316 – 321
65.
Anglin DM, Lui F, Schneider M, et al : Changes in perceived neighborhood ethnic density among racial and ethnic minorities over time and psychotic-like experiences. Schizophr Res 2020 ; 216 : 330 – 338
66.
Ku BS, Pauselli L, Manseau M, et al : Neighborhood-level predictors of age at onset and duration of untreated psychosis in first-episode psychotic disorders. Schizophr Res 2020 ; 218 : 247 – 254
67.
Engemann K, Pedersen CB, Arge L, et al : Childhood exposure to green space: a novel risk-decreasing mechanism for schizophrenia? Schizophr Res 2018 ; 199 : 142 – 148
68.
Attademo L, Bernardini F, Garinella R, et al : Environmental pollution and risk of psychotic disorders: a review of the science to date. Schizophr Res 2017 ; 181 : 55 – 59
69.
Grattan RE, Linscott RJ : Components of schizophrenia liability affect the growth of psychological stress sensitivity following major life events. Schizophr Res 2019 ; 212 : 134 – 139
70.
Labad J : The role of cortisol and prolactin in the pathogenesis and clinical expression of psychotic disorders. Psychoneuroendocrinology 2019 ; 102 : 24 – 36
71.
Selten J-P, van der Ven E, Rutten BPF, et al : The social defeat hypothesis of schizophrenia: an update. Schizophr Bull 2013 ; 39 : 1180 – 1186
72.
Roberts AL, Gilman SE, Breslau J, et al : Race/ethnic differences in exposure to traumatic events, development of post-traumatic stress disorder, and treatment-seeking for post-traumatic stress disorder in the United States. Psychol Med 2011 ; 41 : 71 – 83
73.
Barzilay R, Calkins ME, Moore TM, et al : Association between traumatic stress load, psychopathology, and cognition in the Philadelphia Neurodevelopmental Cohort. Psychol Med 2019 ; 49 : 325 – 334
74.
Ered A, Ellman LM : Specificity of childhood trauma type and attenuated positive symptoms in a non-clinical sample. J Clin Med 2019 ; 8 : 1537
75.
Stickley A, Waldman K, Sumiyoshi T, et al : Childhood physical neglect and psychotic experiences: Findings from the National Comorbidity Survey Replication. Early Interv Psychiatry 2020 ; 15 : 256 – 262
76.
Stowkowy J, Liu L, Cadenhead KS, et al : Early traumatic experiences, perceived discrimination, and conversion to psychosis in those at clinical high risk for psychosis. Soc Psychiatry Psychiatr Epidemiol 2016 ; 51 : 497 – 503
77.
Strauss GP, Raugh IM, Mittal VA, et al : Bullying victimization and perpetration in a community sample of youth with psychotic like experiences. Schizophr Res 2018 ; 195 : 534 – 536
78.
Vargas T, Damme KSF, Mittal VA : Bullying victimization in typically developing and clinical high risk (CHR) adolescents: a multimodal imaging study. Schizophr Res 2019 ; 213 : 40 – 47
79.
Shin SH : Need for and actual use of mental health service by adolescents in the child welfare system. Child Youth Serv Rev 2005 ; 27 : 1071 – 1083
80.
Thompson JL, Kelly M, Kimhy D, et al : Childhood trauma and prodromal symptoms among individuals at clinical high risk for psychosis. Schizophr Res 2009 ; 108 : 176 – 181
81.
Rosenberg SD, Lu W, Mueser KT, et al : Correlates of adverse childhood events among adults with schizophrenia spectrum disorders. Psychiatr Serv 2007 ; 58 : 245 – 253
82.
Anglin DM, Lighty Q, Greenspoon M, et al : Racial discrimination is associated with distressing subthreshold positive psychotic symptoms among US urban ethnic minority young adults. Soc Psychiatry Psychiatr Epidemiol 2014 ; 49 : 1545 – 1555
83.
Oh H, Yang LH, Anglin DM, et al : Perceived discrimination and psychotic experiences across multiple ethnic groups in the United States. Schizophr Res 2014 ; 157 : 259 – 265
84.
Kline E, Millman ZB, Denenny D, et al : Trauma and psychosis symptoms in a sample of help-seeking youth. Schizophr Res 2016 ; 175 : 174 – 179
85.
Shevlin M, Houston JE, Dorahy MJ, et al : Cumulative traumas and psychosis: an analysis of the National Comorbidity Survey and the British Psychiatric Morbidity Survey. Schizophr Bull 2008 ; 34 : 193 – 199
86.
Read J, van Os J, Morrison AP, et al : Childhood trauma, psychosis, and schizophrenia: a literature review with theoretical and clinical implications. Acta Psychiatr Scand 2005 ; 112 : 330 – 350
87.
Read J, Fosse R, Moskowitz A, et al : The traumagenic neurodevelopmental model of psychosis revisited. Neuropsychiatry (London) 2014 ; 4 : 65 – 79
88.
DeCamp W, Zaykowski H : Developmental victimology: estimating group victimization trajectories in the age-victimization curve. Int Rev Vict. 2015 ; 21 : 255 – 272
89.
Poulton R, Van Ryzin MJ, Harold GT, et al : Effects of multidimensional treatment foster care on psychotic symptoms in girls. J Am Acad Child Adolesc Psychiatry 2014 ; 53 : 1279 – 1287
90.
Evans AC, Anthony CE : Gun violence: a public health problem. The Hill, April 6, 2018
91.
American Public Health Association : Addressing law enforcement violence as a public health issue (policy statement). November 13, 2018 ( https://www.apha.org/policies-and-advocacy/public-health-policy-statements/policy-database/2019/01/29/law-enforcement-violence )
92.
Devylder JE, Fedina L, Link BG : Impact of police violence on mental health: a theoretical framework. Am J Public Health 2020 ; 110 : 1704 – 1710
93.
Edwards F, Lee H, Esposito M : Risk of being killed by police use of force in the United States by age, race-ethnicity, and sex. Proc Natl Acad Sci USA 2019 ; 116 : 16793 – 16798
94.
Smith ME, Sharpe TL, Richardson J, et al : The impact of exposure to gun violence fatality on mental health outcomes in four urban US settings. Soc Sci Med 2020 ; 246 : 112587
95.
Centers for Disease Control and Prevention: WISQARS Leading Causes of Death Reports, 1981–2018. https://webappa.cdc.gov/sasweb/ncipc/leadcause.html
97.
DeVylder JE, Cogburn C, Oh HY, et al : Psychotic experiences in the context of police victimization: data from the Survey of Police-Public Encounters. Schizophr Bull 2017 ; 43 : 993 – 1001
98.
Davies C, Segre G, Estradé A, et al : Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysis. Lancet Psychiatry 2020 ; 7 : 399 – 410
99.
Brown AS : Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. Dev Neurobiol 2012 ; 72 : 1272 – 1276
100.
Ellman LM, Susser ES : The promise of epidemiologic studies: neuroimmune mechanisms in the etiologies of brain disorders. Neuron 2009 ; 64 : 25 – 27
101.
Fineberg AM, Ellman LM : Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia. Biol Psychiatry 2013 ; 73 : 951 – 66
102.
Fineberg AM, Ellman LM, Schaefer CA, et al : Fetal exposure to maternal stress and risk for schizophrenia spectrum disorders among offspring: differential influences of fetal sex. Psychiatry Res 2016 ; 236 : 91 – 97
103.
Lipner E, Murphy SK, Ellman LM : Prenatal maternal stress and the cascade of risk to schizophrenia spectrum disorders in offspring. Curr Psychiatry Rep 2019 ; 21 : 99
104.
Mittal VA, Ellman LM, Cannon TD : Gene-environment interaction and covariation in schizophrenia: the role of obstetric complications. Schizophr Bull 2008 ; 34 : 1083 – 1094
105.
Ellman LM, Murphy SK, Maxwell SD, et al : Maternal cortisol during pregnancy and offspring schizophrenia: influence of fetal sex and timing of exposure. Schizophr Res 2019 ; 213 : 15 – 22
106.
Fineberg AM, Ellman LM, Buka S, et al : Decreased birth weight in psychosis: influence of prenatal exposure to serologically determined influenza and hypoxia. Schizophr Bull 2013 ; 39 : 1037 – 1044
107.
Ellman LM, Vinogradov S, Kremen WS, et al : Low maternal hemoglobin during pregnancy and diminished neuromotor and neurocognitive performance in offspring with schizophrenia. Schizophr Res 2012 ; 138 : 81 – 87
108.
Brown AS, Susser ES : Prenatal nutritional deficiency and risk of adult schizophrenia. Schizophr Bull 2008 ; 34 : 1054 – 1063
109.
Ellman LM, Ma SKM, Maxwell SD : Pre- and perinatal risk factors for serious mental disorders: ethical considerations in prevention and prediction efforts. J Ethics Ment Health 2018 ; 10 : 1 – 14
110.
Cannon TD, Rosso IM, Hollister JM, et al : A prospective cohort study of genetic and perinatal influences in the etiology of schizophrenia. Schizophr Bull 2000 ; 26 : 351 – 366
111.
Susser ES, Schaefer CA, Brown AS, et al : The design of the prenatal determinants of schizophrenia study. Schizophr Bull 2000 ; 26 : 257 – 273
112.
Giscombé CL, Lobel M : Explaining disproportionately high rates of adverse birth outcomes among African Americans: the impact of stress, racism, and related factors in pregnancy. Psychol Bull 2005 ; 131 : 662 – 683
113.
Menon R, Dunlop AL, Kramer MR, et al : An overview of racial disparities in preterm birth rates: caused by infection or inflammatory response? Acta Obstet Gynecol Scand 2011 ; 90 : 1325 – 1331
114.
Lu MC, Halfon N : Racial and ethnic disparities in birth outcomes: a life-course perspective. Matern Child Health J 2003 ; 7 : 13 – 30
115.
Bekkar B, Pacheco S, Basu R, et al : Association of air pollution and heat exposure with preterm birth, low birth weight, and stillbirth in the US: a systematic review. JAMA Netw Open 2020 ; 3 : e208243
116.
Padula AM, Monk C, Brennan PA, et al : A review of maternal prenatal exposures to environmental chemicals and psychosocial stressors: implications for research on perinatal outcomes in the ECHO program. J Perinatol 2020 ; 40 : 10 – 24
117.
Giurgescu C, Zenk SN, Templin TN, et al : The impact of neighborhood conditions and psychological distress on preterm birth in African-American women. Public Health Nurs 2017 ; 34 : 256 – 266
118.
Lu MC, Chen B : Racial and ethnic disparities in preterm birth: the role of stressful life events. Am J Obstet Gynecol 2004 ; 191 : 691 – 699
119.
Dominguez TP, Dunkel-Schetter C, Glynn LM, et al : Racial differences in birth outcomes: the role of general, pregnancy, and racism stress. Health Psychol 2008 ; 27 : 194 – 203
120.
Glynn LM, Schetter CD, Chicz-DeMet A, et al : Ethnic differences in adrenocorticotropic hormone, cortisol, and corticotropin-releasing hormone during pregnancy. Peptides 2007 ; 28 : 1155 – 1161
121.
Murphy VE, Smith R, Giles WB, et al : Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. Endocr Rev 2006 ; 27 : 141 – 169
122.
Trainer PJ : Corticosteroids and pregnancy. Semin Reprod Med 2002 ; 20 : 375 – 380
123.
Welberg LAM, Seckl JR, Holmes MC : Prenatal glucocorticoid programming of brain corticosteroid receptors and corticotrophin-releasing hormone: possible implications for behaviour. Neuroscience 2001 ; 104 : 71 – 79
124.
Holzman C, Jetton J, Siler-Khodr T, et al : Second trimester corticotropin-releasing hormone levels in relation to preterm delivery and ethnicity. Obstet Gynecol 2001 ; 97 : 657 – 663
125.
Borders AEB, Wolfe K, Qadir S, et al : Racial/ethnic differences in self-reported and biologic measures of chronic stress in pregnancy. J Perinatol 2015 ; 35 : 580 – 584
126.
Gillespie SL, Porter K, Christian LM : Adaptation of the inflammatory immune response across pregnancy and postpartum in Black and White women. J Reprod Immunol 2016 ; 114 : 27 – 31
127.
Conradt E, Carter SE, Crowell SE : Biological embedding of chronic stress across two generations within marginalized communities. Child Dev Perspect 2020 ; 14 : 208 – 214
128.
Campos B, Schetter CD, Abdou CM, et al : Familialism, social support, and stress: positive implications for pregnant Latinas. Cultur Divers Ethnic Minor Psychol 2008 ; 14 : 155 – 162
129.
Premkumar A, Debbink MP, Silver RM, et al : Association of acculturation with adverse pregnancy outcomes. Obstet Gynecol 2020 ; 135 : 301 – 309
130.
Fuentes-Afflick E, Lurie P : Low birth weight and Latino ethnicity: examining the epidemiologic paradox. Arch Pediatr Adolesc Med 1997 ; 151 : 665 – 674
131.
Callister LC, Birkhead A : Acculturation and perinatal outcomes in Mexican immigrant childbearing women: an integrative review. J Perinat Neonatal Nurs 2002 ; 16 : 22 – 38
132.
Fox M, Entringer S, Buss C, et al : Intergenerational transmission of the effects of acculturation on health in Hispanic Americans: a fetal programming perspective. Am J Public Health 2015 ; 105 ( Suppl 3 ): S409 – S423
133.
Morales LS, Lara M, Kington RS, et al : Socioeconomic, cultural, and behavioral factors affecting Hispanic health outcomes. J Health Care Poor Underserved 2002 ; 13 : 477 – 503
134.
D’Anna-Hernandez KL, Hoffman MC, Zerbe GO, et al : Acculturation, maternal cortisol, and birth outcomes in women of Mexican descent. Psychosom Med 2012 ; 74 : 296 – 304
135.
Scholaske L, Buss C, Wadhwa PD, et al : Acculturation and interleukin (IL)-6 concentrations across pregnancy among Mexican-American women. Brain Behav Immun 2018 ; 73 : 731 – 735
136.
American Psychological Association: Stress and Health Disparities: Contexts Mechanisms, and Interventions Among Racial/Ethnic Minority and Low Socioeconomic Status Populations. Washington, DC, American Psychological Association, 2017 ( https://www.apa.org/pi/health-disparities/resources/stress-report.pdf )
137.
Combs DR, Penn DL, Cassisi J, et al : Perceived racism as a predictor of paranoia among African Americans. J Black Psychol 2006 ; 32 : 87 – 104
138.
Kong DT : Ethnic minorities’ paranoia and self-preservative work behaviors in response to perceived ethnic discrimination, with collective self-esteem as a buffer. J Occup Health Psychol 2016 ; 21 : 334 – 351
139.
Harnett NG, Wheelock MD, Wood KH, et al : Negative life experiences contribute to racial differences in the neural response to threat. Neuroimage 2019 ; 202 : 116086
140.
Gur RE, Moore TM, Rosen AFG, et al : Burden of environmental adversity associated with psychopathology, maturation, and brain behavior parameters in youths. JAMA Psychiatry 2019 ; 76 : 966 – 975
141.
Carter SE, Ong ML, Simons RL, et al : The effect of early discrimination on accelerated aging among African Americans. Health Psychol 2019 ; 38 : 1010 – 1013
142.
Grzanka PR, Gonzalez KA, Spanierman LB : White supremacy and counseling psychology: a critical-conceptual framework. Couns Psychol 2019 ; 47 : 478 – 529
143.
Abbass-Dick J, Sun W, Stanyon WM, et al : Designing a mindfulness resource for expectant and new mothers to promote maternal mental wellness: parents’ knowledge, attitudes, and learning preferences. J Child Fam Stud 2020 ; 29 : 105 – 114
144.
Sabnis A, Fojo S, Nayak SS, et al : Reducing parental trauma and stress in neonatal intensive care: systematic review and meta-analysis of hospital interventions. J Perinatol 2019 ; 39 : 375 – 386
145.
van der Ven E, Susser E, Dixon LB, et al : Racial-ethnic differences in service use patterns among young, commercially insured individuals with recent-onset psychosis. Psychiatr Serv 2020 ; 71 : 433 – 439
146.
Castillo EG, Ijadi-Maghsoodi R, Shadravan S, et al : Community interventions to promote mental health and social equity. Curr Psychiatry Rep 2019 ; 21 : 1 – 14
147.
Hankerson SH, Wells K, Sullivan MA, et al : Partnering with African American churches to create a community coalition for mental health. Ethn Dis 2018 ; 28 ( suppl 2 ): 467 – 474
148.
Comas-Díaz L, Hall GN, Neville HA : Racial trauma: theory, research, and healing: introduction to the special issue. Am Psychol 2019 ; 74 : 1 – 5
149.
150.
Lewis-Fernández R, Díaz N : The cultural formulation: a method for assessing cultural factors affecting the clinical encounter. Psychiatr Q 2002 ; 72 : 271 – 295
151.
Adeponle AB, Groleau D, Kirmayer LJ : Clinician reasoning in the use of cultural formulation to resolve uncertainty in the diagnosis of psychosis. Cult Med Psychiatry 2015 ; 39 : 16 – 42
152.
Metzl JM, Hansen H : Structural competency and psychiatry. JAMA Psychiatry 2018 ; 75 : 115 – 116
153.
George P, Rosenblatt A, Daley T, et al : The early psychosis intervention network (EPINET) national core assessment battery: building the foundation for a learning health care partnership, in the American Public Health Association’s VIRTUAL Annual Meeting and Expo. American Public Health Association, 2020
154.
Weisman de Mamani A, Weintraub MJ, Gurak K, et al : A randomized clinical trial to test the efficacy of a family-focused, culturally informed therapy for schizophrenia. J Fam Psychol 2014 ; 28 : 800 – 810
155.
Neblett EW : Racism and health: challenges and future directions in behavioral and psychological research. Cultur Divers Ethnic Minor Psychol 2019 ; 25 : 12 – 20
156.
Wang CC, Yi WK, Tao ZW, et al : Photovoice as a participatory health promotion strategy. Health Promot Int 1998 ; 13 : 75 – 86
157.
Hergenrather KC, Rhodes SD, Cowan CA, et al : Photovoice as community-based participatory research: a qualitative review. Am J Health Behav 2009 ; 33 : 686 – 698
158.
Call-Cummings M, Hauber-Özer M, Byers C, et al : The power of/in Photovoice. Int J Res Method Educ 2019 ; 42 : 399 – 413
159.
Wang CC. Photovoice: a participatory action research strategy applied to women’s health. J Women’s Health 1999 ; 8 : 185 – 192

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 599 - 610
PubMed: 33934608

History

Received: 22 July 2020
Revision received: 17 December 2020
Accepted: 11 January 2021
Published online: 3 May 2021
Published in print: July 2021

Keywords

  1. Schizophrenia Spectrum and Other Psychotic Disorders
  2. Sociopolitical Issues
  3. Racism
  4. Environmental Risk Factors

Authors

Details

Deidre M. Anglin, Ph.D. [email protected]
Department of Psychology, City College of New York, City University of New York, New York (Anglin, Thayer); Graduate Center, City University of New York (Anglin); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Ereshefsky, Niendam, Bolden, Grattan); Department of Psychology, University of Maryland, Baltimore County (Klaunig, Bridgwater, Schiffman); Department of Psychology, Temple University, Philadelphia (Ellman, Lipner); Graduate School of Social Service, Fordham University, New York (DeVylder); Department of Psychology (Musket) and Department of Psychiatry (Bachman), University of Pittsburgh, Pittsburgh; ISN Innovations, Institute for Social Neuroscience, Ivanhoe, Australia (Grattan); Department of Psychological Sciences, Case Western Reserve University, Cleveland (Lincoln); Department of Psychological Science, University of California, Irvine (Schiffman); Department of Psychiatry, Icahn School of Medicine, New York, and James J. Peters VA Medical Center, Bronx, N.Y. (Corcoran); Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil (Mota); Mailman School of Public Health, Columbia University, New York (van der Ven); School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands (van der Ven); Department of Clinical, Neuro, and Developmental Psychology, Vrije Universiteit (VU) Amsterdam, Amsterdam (van der Ven)
Sabrina Ereshefsky, Ph.D.
Department of Psychology, City College of New York, City University of New York, New York (Anglin, Thayer); Graduate Center, City University of New York (Anglin); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Ereshefsky, Niendam, Bolden, Grattan); Department of Psychology, University of Maryland, Baltimore County (Klaunig, Bridgwater, Schiffman); Department of Psychology, Temple University, Philadelphia (Ellman, Lipner); Graduate School of Social Service, Fordham University, New York (DeVylder); Department of Psychology (Musket) and Department of Psychiatry (Bachman), University of Pittsburgh, Pittsburgh; ISN Innovations, Institute for Social Neuroscience, Ivanhoe, Australia (Grattan); Department of Psychological Sciences, Case Western Reserve University, Cleveland (Lincoln); Department of Psychological Science, University of California, Irvine (Schiffman); Department of Psychiatry, Icahn School of Medicine, New York, and James J. Peters VA Medical Center, Bronx, N.Y. (Corcoran); Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil (Mota); Mailman School of Public Health, Columbia University, New York (van der Ven); School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands (van der Ven); Department of Clinical, Neuro, and Developmental Psychology, Vrije Universiteit (VU) Amsterdam, Amsterdam (van der Ven)
Mallory J. Klaunig, Ph.D.
Department of Psychology, City College of New York, City University of New York, New York (Anglin, Thayer); Graduate Center, City University of New York (Anglin); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Ereshefsky, Niendam, Bolden, Grattan); Department of Psychology, University of Maryland, Baltimore County (Klaunig, Bridgwater, Schiffman); Department of Psychology, Temple University, Philadelphia (Ellman, Lipner); Graduate School of Social Service, Fordham University, New York (DeVylder); Department of Psychology (Musket) and Department of Psychiatry (Bachman), University of Pittsburgh, Pittsburgh; ISN Innovations, Institute for Social Neuroscience, Ivanhoe, Australia (Grattan); Department of Psychological Sciences, Case Western Reserve University, Cleveland (Lincoln); Department of Psychological Science, University of California, Irvine (Schiffman); Department of Psychiatry, Icahn School of Medicine, New York, and James J. Peters VA Medical Center, Bronx, N.Y. (Corcoran); Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil (Mota); Mailman School of Public Health, Columbia University, New York (van der Ven); School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands (van der Ven); Department of Clinical, Neuro, and Developmental Psychology, Vrije Universiteit (VU) Amsterdam, Amsterdam (van der Ven)
Miranda A. Bridgwater, B.S.
Department of Psychology, City College of New York, City University of New York, New York (Anglin, Thayer); Graduate Center, City University of New York (Anglin); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Ereshefsky, Niendam, Bolden, Grattan); Department of Psychology, University of Maryland, Baltimore County (Klaunig, Bridgwater, Schiffman); Department of Psychology, Temple University, Philadelphia (Ellman, Lipner); Graduate School of Social Service, Fordham University, New York (DeVylder); Department of Psychology (Musket) and Department of Psychiatry (Bachman), University of Pittsburgh, Pittsburgh; ISN Innovations, Institute for Social Neuroscience, Ivanhoe, Australia (Grattan); Department of Psychological Sciences, Case Western Reserve University, Cleveland (Lincoln); Department of Psychological Science, University of California, Irvine (Schiffman); Department of Psychiatry, Icahn School of Medicine, New York, and James J. Peters VA Medical Center, Bronx, N.Y. (Corcoran); Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil (Mota); Mailman School of Public Health, Columbia University, New York (van der Ven); School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands (van der Ven); Department of Clinical, Neuro, and Developmental Psychology, Vrije Universiteit (VU) Amsterdam, Amsterdam (van der Ven)
Tara A. Niendam, Ph.D.
Department of Psychology, City College of New York, City University of New York, New York (Anglin, Thayer); Graduate Center, City University of New York (Anglin); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Ereshefsky, Niendam, Bolden, Grattan); Department of Psychology, University of Maryland, Baltimore County (Klaunig, Bridgwater, Schiffman); Department of Psychology, Temple University, Philadelphia (Ellman, Lipner); Graduate School of Social Service, Fordham University, New York (DeVylder); Department of Psychology (Musket) and Department of Psychiatry (Bachman), University of Pittsburgh, Pittsburgh; ISN Innovations, Institute for Social Neuroscience, Ivanhoe, Australia (Grattan); Department of Psychological Sciences, Case Western Reserve University, Cleveland (Lincoln); Department of Psychological Science, University of California, Irvine (Schiffman); Department of Psychiatry, Icahn School of Medicine, New York, and James J. Peters VA Medical Center, Bronx, N.Y. (Corcoran); Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil (Mota); Mailman School of Public Health, Columbia University, New York (van der Ven); School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands (van der Ven); Department of Clinical, Neuro, and Developmental Psychology, Vrije Universiteit (VU) Amsterdam, Amsterdam (van der Ven)
Lauren M. Ellman, Ph.D.
Department of Psychology, City College of New York, City University of New York, New York (Anglin, Thayer); Graduate Center, City University of New York (Anglin); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Ereshefsky, Niendam, Bolden, Grattan); Department of Psychology, University of Maryland, Baltimore County (Klaunig, Bridgwater, Schiffman); Department of Psychology, Temple University, Philadelphia (Ellman, Lipner); Graduate School of Social Service, Fordham University, New York (DeVylder); Department of Psychology (Musket) and Department of Psychiatry (Bachman), University of Pittsburgh, Pittsburgh; ISN Innovations, Institute for Social Neuroscience, Ivanhoe, Australia (Grattan); Department of Psychological Sciences, Case Western Reserve University, Cleveland (Lincoln); Department of Psychological Science, University of California, Irvine (Schiffman); Department of Psychiatry, Icahn School of Medicine, New York, and James J. Peters VA Medical Center, Bronx, N.Y. (Corcoran); Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil (Mota); Mailman School of Public Health, Columbia University, New York (van der Ven); School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands (van der Ven); Department of Clinical, Neuro, and Developmental Psychology, Vrije Universiteit (VU) Amsterdam, Amsterdam (van der Ven)
Jordan DeVylder, Ph.D.
Department of Psychology, City College of New York, City University of New York, New York (Anglin, Thayer); Graduate Center, City University of New York (Anglin); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Ereshefsky, Niendam, Bolden, Grattan); Department of Psychology, University of Maryland, Baltimore County (Klaunig, Bridgwater, Schiffman); Department of Psychology, Temple University, Philadelphia (Ellman, Lipner); Graduate School of Social Service, Fordham University, New York (DeVylder); Department of Psychology (Musket) and Department of Psychiatry (Bachman), University of Pittsburgh, Pittsburgh; ISN Innovations, Institute for Social Neuroscience, Ivanhoe, Australia (Grattan); Department of Psychological Sciences, Case Western Reserve University, Cleveland (Lincoln); Department of Psychological Science, University of California, Irvine (Schiffman); Department of Psychiatry, Icahn School of Medicine, New York, and James J. Peters VA Medical Center, Bronx, N.Y. (Corcoran); Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil (Mota); Mailman School of Public Health, Columbia University, New York (van der Ven); School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands (van der Ven); Department of Clinical, Neuro, and Developmental Psychology, Vrije Universiteit (VU) Amsterdam, Amsterdam (van der Ven)
Griffin Thayer, M.A.
Department of Psychology, City College of New York, City University of New York, New York (Anglin, Thayer); Graduate Center, City University of New York (Anglin); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Ereshefsky, Niendam, Bolden, Grattan); Department of Psychology, University of Maryland, Baltimore County (Klaunig, Bridgwater, Schiffman); Department of Psychology, Temple University, Philadelphia (Ellman, Lipner); Graduate School of Social Service, Fordham University, New York (DeVylder); Department of Psychology (Musket) and Department of Psychiatry (Bachman), University of Pittsburgh, Pittsburgh; ISN Innovations, Institute for Social Neuroscience, Ivanhoe, Australia (Grattan); Department of Psychological Sciences, Case Western Reserve University, Cleveland (Lincoln); Department of Psychological Science, University of California, Irvine (Schiffman); Department of Psychiatry, Icahn School of Medicine, New York, and James J. Peters VA Medical Center, Bronx, N.Y. (Corcoran); Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil (Mota); Mailman School of Public Health, Columbia University, New York (van der Ven); School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands (van der Ven); Department of Clinical, Neuro, and Developmental Psychology, Vrije Universiteit (VU) Amsterdam, Amsterdam (van der Ven)
Khalima Bolden, Ph.D.
Department of Psychology, City College of New York, City University of New York, New York (Anglin, Thayer); Graduate Center, City University of New York (Anglin); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Ereshefsky, Niendam, Bolden, Grattan); Department of Psychology, University of Maryland, Baltimore County (Klaunig, Bridgwater, Schiffman); Department of Psychology, Temple University, Philadelphia (Ellman, Lipner); Graduate School of Social Service, Fordham University, New York (DeVylder); Department of Psychology (Musket) and Department of Psychiatry (Bachman), University of Pittsburgh, Pittsburgh; ISN Innovations, Institute for Social Neuroscience, Ivanhoe, Australia (Grattan); Department of Psychological Sciences, Case Western Reserve University, Cleveland (Lincoln); Department of Psychological Science, University of California, Irvine (Schiffman); Department of Psychiatry, Icahn School of Medicine, New York, and James J. Peters VA Medical Center, Bronx, N.Y. (Corcoran); Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil (Mota); Mailman School of Public Health, Columbia University, New York (van der Ven); School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands (van der Ven); Department of Clinical, Neuro, and Developmental Psychology, Vrije Universiteit (VU) Amsterdam, Amsterdam (van der Ven)
Christie W. Musket, M.S.
Department of Psychology, City College of New York, City University of New York, New York (Anglin, Thayer); Graduate Center, City University of New York (Anglin); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Ereshefsky, Niendam, Bolden, Grattan); Department of Psychology, University of Maryland, Baltimore County (Klaunig, Bridgwater, Schiffman); Department of Psychology, Temple University, Philadelphia (Ellman, Lipner); Graduate School of Social Service, Fordham University, New York (DeVylder); Department of Psychology (Musket) and Department of Psychiatry (Bachman), University of Pittsburgh, Pittsburgh; ISN Innovations, Institute for Social Neuroscience, Ivanhoe, Australia (Grattan); Department of Psychological Sciences, Case Western Reserve University, Cleveland (Lincoln); Department of Psychological Science, University of California, Irvine (Schiffman); Department of Psychiatry, Icahn School of Medicine, New York, and James J. Peters VA Medical Center, Bronx, N.Y. (Corcoran); Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil (Mota); Mailman School of Public Health, Columbia University, New York (van der Ven); School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands (van der Ven); Department of Clinical, Neuro, and Developmental Psychology, Vrije Universiteit (VU) Amsterdam, Amsterdam (van der Ven)
Rebecca E. Grattan, Ph.D.
Department of Psychology, City College of New York, City University of New York, New York (Anglin, Thayer); Graduate Center, City University of New York (Anglin); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Ereshefsky, Niendam, Bolden, Grattan); Department of Psychology, University of Maryland, Baltimore County (Klaunig, Bridgwater, Schiffman); Department of Psychology, Temple University, Philadelphia (Ellman, Lipner); Graduate School of Social Service, Fordham University, New York (DeVylder); Department of Psychology (Musket) and Department of Psychiatry (Bachman), University of Pittsburgh, Pittsburgh; ISN Innovations, Institute for Social Neuroscience, Ivanhoe, Australia (Grattan); Department of Psychological Sciences, Case Western Reserve University, Cleveland (Lincoln); Department of Psychological Science, University of California, Irvine (Schiffman); Department of Psychiatry, Icahn School of Medicine, New York, and James J. Peters VA Medical Center, Bronx, N.Y. (Corcoran); Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil (Mota); Mailman School of Public Health, Columbia University, New York (van der Ven); School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands (van der Ven); Department of Clinical, Neuro, and Developmental Psychology, Vrije Universiteit (VU) Amsterdam, Amsterdam (van der Ven)
Sarah Hope Lincoln, Ph.D.
Department of Psychology, City College of New York, City University of New York, New York (Anglin, Thayer); Graduate Center, City University of New York (Anglin); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Ereshefsky, Niendam, Bolden, Grattan); Department of Psychology, University of Maryland, Baltimore County (Klaunig, Bridgwater, Schiffman); Department of Psychology, Temple University, Philadelphia (Ellman, Lipner); Graduate School of Social Service, Fordham University, New York (DeVylder); Department of Psychology (Musket) and Department of Psychiatry (Bachman), University of Pittsburgh, Pittsburgh; ISN Innovations, Institute for Social Neuroscience, Ivanhoe, Australia (Grattan); Department of Psychological Sciences, Case Western Reserve University, Cleveland (Lincoln); Department of Psychological Science, University of California, Irvine (Schiffman); Department of Psychiatry, Icahn School of Medicine, New York, and James J. Peters VA Medical Center, Bronx, N.Y. (Corcoran); Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil (Mota); Mailman School of Public Health, Columbia University, New York (van der Ven); School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands (van der Ven); Department of Clinical, Neuro, and Developmental Psychology, Vrije Universiteit (VU) Amsterdam, Amsterdam (van der Ven)
Jason Schiffman, Ph.D.
Department of Psychology, City College of New York, City University of New York, New York (Anglin, Thayer); Graduate Center, City University of New York (Anglin); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Ereshefsky, Niendam, Bolden, Grattan); Department of Psychology, University of Maryland, Baltimore County (Klaunig, Bridgwater, Schiffman); Department of Psychology, Temple University, Philadelphia (Ellman, Lipner); Graduate School of Social Service, Fordham University, New York (DeVylder); Department of Psychology (Musket) and Department of Psychiatry (Bachman), University of Pittsburgh, Pittsburgh; ISN Innovations, Institute for Social Neuroscience, Ivanhoe, Australia (Grattan); Department of Psychological Sciences, Case Western Reserve University, Cleveland (Lincoln); Department of Psychological Science, University of California, Irvine (Schiffman); Department of Psychiatry, Icahn School of Medicine, New York, and James J. Peters VA Medical Center, Bronx, N.Y. (Corcoran); Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil (Mota); Mailman School of Public Health, Columbia University, New York (van der Ven); School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands (van der Ven); Department of Clinical, Neuro, and Developmental Psychology, Vrije Universiteit (VU) Amsterdam, Amsterdam (van der Ven)
Emily Lipner, M.A.
Department of Psychology, City College of New York, City University of New York, New York (Anglin, Thayer); Graduate Center, City University of New York (Anglin); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Ereshefsky, Niendam, Bolden, Grattan); Department of Psychology, University of Maryland, Baltimore County (Klaunig, Bridgwater, Schiffman); Department of Psychology, Temple University, Philadelphia (Ellman, Lipner); Graduate School of Social Service, Fordham University, New York (DeVylder); Department of Psychology (Musket) and Department of Psychiatry (Bachman), University of Pittsburgh, Pittsburgh; ISN Innovations, Institute for Social Neuroscience, Ivanhoe, Australia (Grattan); Department of Psychological Sciences, Case Western Reserve University, Cleveland (Lincoln); Department of Psychological Science, University of California, Irvine (Schiffman); Department of Psychiatry, Icahn School of Medicine, New York, and James J. Peters VA Medical Center, Bronx, N.Y. (Corcoran); Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil (Mota); Mailman School of Public Health, Columbia University, New York (van der Ven); School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands (van der Ven); Department of Clinical, Neuro, and Developmental Psychology, Vrije Universiteit (VU) Amsterdam, Amsterdam (van der Ven)
Peter Bachman, Ph.D.
Department of Psychology, City College of New York, City University of New York, New York (Anglin, Thayer); Graduate Center, City University of New York (Anglin); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Ereshefsky, Niendam, Bolden, Grattan); Department of Psychology, University of Maryland, Baltimore County (Klaunig, Bridgwater, Schiffman); Department of Psychology, Temple University, Philadelphia (Ellman, Lipner); Graduate School of Social Service, Fordham University, New York (DeVylder); Department of Psychology (Musket) and Department of Psychiatry (Bachman), University of Pittsburgh, Pittsburgh; ISN Innovations, Institute for Social Neuroscience, Ivanhoe, Australia (Grattan); Department of Psychological Sciences, Case Western Reserve University, Cleveland (Lincoln); Department of Psychological Science, University of California, Irvine (Schiffman); Department of Psychiatry, Icahn School of Medicine, New York, and James J. Peters VA Medical Center, Bronx, N.Y. (Corcoran); Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil (Mota); Mailman School of Public Health, Columbia University, New York (van der Ven); School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands (van der Ven); Department of Clinical, Neuro, and Developmental Psychology, Vrije Universiteit (VU) Amsterdam, Amsterdam (van der Ven)
Cheryl M. Corcoran, M.D.
Department of Psychology, City College of New York, City University of New York, New York (Anglin, Thayer); Graduate Center, City University of New York (Anglin); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Ereshefsky, Niendam, Bolden, Grattan); Department of Psychology, University of Maryland, Baltimore County (Klaunig, Bridgwater, Schiffman); Department of Psychology, Temple University, Philadelphia (Ellman, Lipner); Graduate School of Social Service, Fordham University, New York (DeVylder); Department of Psychology (Musket) and Department of Psychiatry (Bachman), University of Pittsburgh, Pittsburgh; ISN Innovations, Institute for Social Neuroscience, Ivanhoe, Australia (Grattan); Department of Psychological Sciences, Case Western Reserve University, Cleveland (Lincoln); Department of Psychological Science, University of California, Irvine (Schiffman); Department of Psychiatry, Icahn School of Medicine, New York, and James J. Peters VA Medical Center, Bronx, N.Y. (Corcoran); Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil (Mota); Mailman School of Public Health, Columbia University, New York (van der Ven); School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands (van der Ven); Department of Clinical, Neuro, and Developmental Psychology, Vrije Universiteit (VU) Amsterdam, Amsterdam (van der Ven)
Natália B. Mota, M.D.
Department of Psychology, City College of New York, City University of New York, New York (Anglin, Thayer); Graduate Center, City University of New York (Anglin); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Ereshefsky, Niendam, Bolden, Grattan); Department of Psychology, University of Maryland, Baltimore County (Klaunig, Bridgwater, Schiffman); Department of Psychology, Temple University, Philadelphia (Ellman, Lipner); Graduate School of Social Service, Fordham University, New York (DeVylder); Department of Psychology (Musket) and Department of Psychiatry (Bachman), University of Pittsburgh, Pittsburgh; ISN Innovations, Institute for Social Neuroscience, Ivanhoe, Australia (Grattan); Department of Psychological Sciences, Case Western Reserve University, Cleveland (Lincoln); Department of Psychological Science, University of California, Irvine (Schiffman); Department of Psychiatry, Icahn School of Medicine, New York, and James J. Peters VA Medical Center, Bronx, N.Y. (Corcoran); Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil (Mota); Mailman School of Public Health, Columbia University, New York (van der Ven); School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands (van der Ven); Department of Clinical, Neuro, and Developmental Psychology, Vrije Universiteit (VU) Amsterdam, Amsterdam (van der Ven)
Els van der Ven, Ph.D.
Department of Psychology, City College of New York, City University of New York, New York (Anglin, Thayer); Graduate Center, City University of New York (Anglin); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Ereshefsky, Niendam, Bolden, Grattan); Department of Psychology, University of Maryland, Baltimore County (Klaunig, Bridgwater, Schiffman); Department of Psychology, Temple University, Philadelphia (Ellman, Lipner); Graduate School of Social Service, Fordham University, New York (DeVylder); Department of Psychology (Musket) and Department of Psychiatry (Bachman), University of Pittsburgh, Pittsburgh; ISN Innovations, Institute for Social Neuroscience, Ivanhoe, Australia (Grattan); Department of Psychological Sciences, Case Western Reserve University, Cleveland (Lincoln); Department of Psychological Science, University of California, Irvine (Schiffman); Department of Psychiatry, Icahn School of Medicine, New York, and James J. Peters VA Medical Center, Bronx, N.Y. (Corcoran); Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil (Mota); Mailman School of Public Health, Columbia University, New York (van der Ven); School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands (van der Ven); Department of Clinical, Neuro, and Developmental Psychology, Vrije Universiteit (VU) Amsterdam, Amsterdam (van der Ven)

Notes

Send correspondence to Dr. Anglin ([email protected]).

Funding Information

Dr. Niendam is a founder and shareholder in Safari Health, Inc. The other authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share